Papatheodoridi M. Rates and predictors of HBsAg loss after discontinuation of effective long-term Entecavir or Tenofovir therapy in non-cirrhotic HBeAg-negative Chronic Hepatitis B patients: Results from the DARING-B prospective Greek study. PS-159.
Hoogtepunten Trends in Medical Mycology (TIMM) 2021
nov 2021 | Schimmelinfecties, Virale infecties